[CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].
The effectiveness of marker CA 15-3 is assessed for the purposes of early diagnosis of breast cancer and its monitoring and data are compared with that of CEA. The results obtained in a series of 71 breast tumours show that CA 15-3 presents high positivity for T2 (66.2%) and possesses greater diagnostic sensitivity and accuracy than CEA.
Festa
V
V
Alabiso
O
O
Piantino
P
P
Lisa
F
F
Zanini
M
M
Garrone
C
C
Simone
P
P
Morino
M
M
D000368:Aged; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests
D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen
Il CA 15-3 nella diagnosi e nel monitoraggio del carcinoma della mammella e sue correlazioni con il CEA.